Tylophorine is an alkaloid isolated from the plant Tylophora indica. It has been shown to possess a wide range of biological activities, including anti-cancer, anti-inflammatory, and anti-microbial properties. Its synthesis has been achieved through various methods, including the use of enzymatic catalysis and palladium-catalyzed reactions. Tylophorine's anti-cancer activity is attributed to its ability to induce apoptosis in cancer cells. Its anti-inflammatory effects are thought to be mediated by its inhibition of inflammatory mediators, such as TNF-alpha and IL-6. Tylophorine has also been shown to exhibit anti-microbial activity against a variety of bacteria and fungi. Due to its promising pharmacological profile, tylophorine has become a target of significant research interest. Scientists are investigating its potential as a therapeutic agent for the treatment of cancer, inflammation, and infectious diseases.'
```
tylophorine: phenanthroindolizidine alkaloid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 92114 |
CHEMBL ID | 250426 |
CHEBI ID | 9786 |
SCHEMBL ID | 523625 |
MeSH ID | M0045209 |
Synonym |
---|
dibenzo[f,2-b]isoquinoline,9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (13as)- |
NCI60_040526 |
NCI60_041685 |
dibenzo[f,2-b]isoquinoline, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy- |
dibenzo[f,2-b]isoquinoline, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (s)- |
tylophorin |
nsc76387 |
nsc-76387 |
2,6,7-tetramethoxyphenanthro[9,10:6',7']indolizidine |
9,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxydibenzo[f,h]pyrrolo[1,2-b]isoquinoline |
tylophorine |
482-20-2 |
(+)-tylophorine |
nsc717335 |
nsc-717335 |
chebi:9786 , |
CHEMBL250426 |
(13as)-2,3,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine |
2,3,6,7-tetramethoxyphenanthro(9,10:6,7')indolizidine |
dibenzo(f,h)pyrrolo(1,2-b)isoquinoline, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (s)- |
(s)-9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxydibenzo(f,h)pyrrolo(1,2-b)isoquinoline |
nsc 76387 |
unii-o41630y8v3 |
o41630y8v3 , |
SCHEMBL523625 |
tylophorine, (+)- |
dibenzo(f,h)pyrrolo(1,2-b)isoquinoline, 9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (13as)- |
(+)-(s)-tylophorine |
nstp-0g01 |
tylophorine [mi] |
(13as)-9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxydibenzo(f,h)pyrrolo(1,2-b)isoquinoline |
AKOS027326841 |
(s)-2,3,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline |
Q27108498 |
2,3,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline |
DTXSID30964025 |
(s)-9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxydibenzo[f,h]pyrrolo[1,2-b]isoquinoline |
Tylophorine (TYL) is an alkaloid with antiproliferative action in cancer cells.
Excerpt | Reference | Relevance |
---|---|---|
"Tylophorine (TYL) is an alkaloid with antiproliferative action in cancer cells. " | ( Tylophorine reduces protein biosynthesis and rapidly decreases cyclin D1, inhibiting vascular smooth muscle cell proliferation in vitro and in organ culture. Atanasov, AG; Bernhard, D; Blažević, T; Czaloun, C; Dirsch, VM; Feldler, I; Grojer, C; Gruzdaitis, P; Heiss, EH; Joa, H; Messner, B; Proksch, P; Zeller, I, 2019) | 3.4 |
Tylophorine analogs have been shown to exhibit diverse activities against cancer, inflammation, arthritis, and lupus in vivo. Tylophile compounds have been the focus of drug development for decades.
Excerpt | Reference | Relevance |
---|---|---|
"Tylophorine analogs have been shown to exhibit diverse activities against cancer, inflammation, arthritis, and lupus in vivo. " | ( Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication. Baker, DC; Chen, SR; Cheng, Y; Cheng, YC; Dutschman, GE; Francis, S; Fürstner, A; Grill, SP; Gullen, EA; Ha, Y; Lam, W; Lee, KH; Lee, S; Wang, Y; Yang, X, 2017) | 3.34 |
"Tylophorine compounds have been the focus of drug development for decades. " | ( Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget. Chang, CC; Hsu, HY; Lee, CH; Lee, SJ; Lee, YZ; Qiu, YQ; Yang, CW; Yang, RB, 2015) | 1.86 |
Excerpt | Reference | Relevance |
---|---|---|
"Tylophorine treatment increased the accumulation of c-Jun protein, a component of activator protein 1 (AP1), in carcinoma cells." | ( c-Jun-mediated anticancer mechanisms of tylophorine. Chang, HY; Chao, YS; Hsu, HY; Lee, SJ; Lee, YZ; Wu, CM; Yang, CW, 2013) | 1.38 |
Class | Description |
---|---|
organonitrogen heterocyclic compound | Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms. |
organic heteropentacyclic compound | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID316826 | Inhibition of CRE-mediated transcription in human HepG cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID316828 | Inhibition of GRE-mediated transcription in human HepG cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1164329 | Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production after 6 hrs by ELISA | 2014 | ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9 | Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. |
AID648628 | Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay | 2012 | European journal of medicinal chemistry, May, Volume: 51 | Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents. |
AID316823 | Growth inhibition of human PANC1 cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1092197 | In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated left side of Nicotiana tabacum L. leaves assessed as inactivation effect at 100 ug/mL co-incubated with virus measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID316827 | Inhibition of AP1-mediated transcription in human HepG cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1081049 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on whole Nicotiana tabacum leaves followed by smearing with 100 ug/mL compound solution on left side of leaves assessed as viral infection curative effect measured 3 to 4 days post viral inf | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1081058 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on fresh tobacco leaves followed by dipping into compound solution at 100 ug/mL for 20 min and measured 72 hr post compound treatment by half-leaf method | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1081057 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on fresh tobacco leaves followed by dipping into compound solution at 50 ug/mL for 20 min and measured 72 hr post compound treatment by half-leaf method | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1164337 | Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay | 2014 | ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9 | Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. |
AID1081051 | Antiviral activity against Tobacco mosaic virus (TMV) pre-treated with 100 ug/mL compound for 30 min followed by inoculation on left side of Nicotiana tabacum leaves assessed as virus inactivation effect measured 3 to 4 days post viral infection | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1092196 | In vivo antiviral activity against Tobacco mosaic virus (TMV) pre-inoculated Nicotiana tabacum L. leaves assessed as curative effect at 500 ug/mL measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID1092195 | In vivo antiviral activity against Tobacco mosaic virus (TMV) pre-inoculated Nicotiana tabacum L. leaves assessed as curative effect at 100 ug/mL measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID1081059 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on 100 ug/mL compound smeared Nicotiana tabacum leaves assessed as protective effect against viral infection measured 3 to 4 days post viral infection | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1081056 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on fresh tobacco leaves followed by dipping into compound solution at 25 ug/mL for 20 min and measured 72 hr post compound treatment by half-leaf method | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID316825 | Inhibition of NF-kappaB-mediated transcription in human HepG cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1092198 | In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated left side of Nicotiana tabacum L. leaves assessed as inactivation effect at 500 ug/mL co-incubated with virus measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID648632 | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | 2012 | European journal of medicinal chemistry, May, Volume: 51 | Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents. |
AID1164328 | Inhibition of Foxp3 expression in B6 Foxp3-GFP mouse CD4-positive T cells assessed as iTregs at 100 nM after 3 days by flow cytometry | 2014 | ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9 | Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. |
AID316824 | Growth inhibition of human CEM cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1081053 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on fresh tobacco leaves followed by dipping into compound solution for 20 min and measured 72 hr post compound treatment by half-leaf method | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1092193 | In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated right side of Nicotiana tabacum L. leaves assessed as protection effect at 100 ug/mL preincubated 12 hr before viral challenge measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID1092200 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated in 5-6 growth stage leaf assessed as inhibition effect at 500 ug/mL at 25 degC after 72 hr by half-leaf method | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID316822 | Growth inhibition of human HepG cells | 2008 | Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2 | Structural analogs of tylophora alkaloids may not be functional analogs. |
AID1164331 | Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 24 hrs by ELISA | 2014 | ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9 | Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. |
AID1081055 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated on fresh tobacco leaves followed by dipping into compound solution at 5 ug/mL for 20 min and measured 72 hr post compound treatment by half-leaf method | 2010 | Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5 | Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives. |
AID1092194 | In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated right side of Nicotiana tabacum L. leaves assessed as protection effect at 500 ug/mL preincubated 12 hr before viral challenge measured after 3 to 4 days | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID1092199 | Antiviral activity against Tobacco mosaic virus (TMV) inoculated in 5-6 growth stage leaf assessed as inhibition effect at 100 ug/mL at 25 degC after 72 hr by half-leaf method | 2012 | Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41 | Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues. |
AID1164330 | Antiinflammatory activity against BALB/c mouse splenocytes assessed as inhibition of LPS-induced TNFalpha production after 4 hrs by ELISA | 2014 | ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9 | Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity. |
AID308174 | Cytotoxicity against PANC1 cells | 2007 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15 | Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. |
AID688325 | Growth inhibition in human MCF7 cells after 72 hrs by alamar blue assay | 2012 | Bioorganic & medicinal chemistry, Oct-01, Volume: 20, Issue:19 | Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (4.76) | 18.7374 |
1990's | 1 (1.59) | 18.2507 |
2000's | 22 (34.92) | 29.6817 |
2010's | 32 (50.79) | 24.3611 |
2020's | 5 (7.94) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.24) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (3.13%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 62 (96.88%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |